LIXT logo

LIXT

Profile

Full Name

Lixte Biotechnology Holdings, Inc.

Ticker Symbol

LIXT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 25, 2007

Indexes

Not included

Website

http://lixte.com

Employees

2

Key Details

Price

$1.21(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.59(+40.23% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.21
LIXT price is $1.21

30-Day Relative Volume

1.06
LIXT 30-day relative volume is 1.06

Price Performance

Price Today change

0%
LIXT {parameterFullLabel} is unchanged today

Price YTD change

-40.39%
LIXT price is down -40.39% since January 1st

Price 1-year change

-65.23%
LIXT price is down -65.23% year-on-year

Price 3-year change

-92.29%
LIXT price is down -92.29% over the past 3 years

Price Range

Price All-time high

$71.90
LIXT price is currently -98.32% below its historical high of $71.90

Price 3-year low

$1.02
LIXT price is currently +18.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.25M
LIXT market capitalization is $3.25 million

Market cap 3-year change

-87.57%
LIXT market capitalization is down -87.57% over the past 3 years

Market cap All-time high

$69.05M
LIXT market capitalization is currently -95.30% below its historical high of $69.05 million

Market cap sector rank

9.53%
LIXT market capitalization is higher than 9.53% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+19.33%
LIXT shares outstanding is up +19.33% year-on-year

Shares Outstanding 3-Year Change

+95.25%
LIXT shares outstanding is up +95.25% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.40
LIXT beta is 0.40

200-day SMA

$1.90
LIXT price is currently -36.31% below its 200-day simple moving average

50-day SMA

$1.47
LIXT price is currently -17.43% below its 50-day simple moving average

RSI

46.03
LIXT 14-day relative strength index is 46.03

Volume

1.06
LIXT 30-day relative volume is 1.06

ATR

$0.11
LIXT average true range is $0.11

10-day Historical Volatility

87.95%
LIXT 10-day historical volatility is 87.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
LIXT annual revenue value is unknown

Revenue Analysts estimate

-
LIXT annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
LIXT annual revenue 1-year change is unknown

Revenue Sector rank

-
LIXT annual revenue is unknown

EPS

EPS

-$1.59
LIXT annual earnings per share is -$1.59

EPS Analysts estimate

-
LIXT annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+40.23%
LIXT annual earnings per share is up +40.23% year-on-year

EPS Sector rank

44.18%
LIXT annual earnings per share is higher than 44.18% of companies in Healthcare sector

Profit

Gross profit

-
LIXT annual gross profit value is unknown

Gross margin

-
LIXT annual gross profit margin value is unknown

Operating profit

-$3.57M
LIXT annual operating income is -$3.57 million

Operating margin

-
LIXT annual operating profit margin value is unknown

Net income

-$3.59M
LIXT annual net profit is -$3.59 million

Net margin

-
LIXT annual net profit margin value is unknown

Expenses

Total expenses

$3.57M
LIXT annual total expenses is $3.57 million

Operating expenses

$3.57M
LIXT annual total operating expenses is $3.57 million

Cost of goods sold

-
LIXT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$2.85M
LIXT annual SGA is $2.85 million

Depreciation and amortization

-
LIXT annual depreciation & amortization value is unknown

Interest expense

$16.80K
LIXT annual interest expense is $16.80 thousand

Income tax

-
LIXT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$3.57M
LIXT annual earnings before interest & taxes is -$3.57 million

EBITDA

-$3.57M
LIXT annual EBITDA is -$3.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.15M
LIXT annual total assets is $1.15 million

Non current assets

$0.00
LIXT annual long term assets is $0.00

Current assets

$1.15M
LIXT annual total current assets is $1.15 million

Cash and cash equivalents

$1.04M
LIXT annual cash & cash equivalents is $1.04 million

Accounts receivable

-
LIXT annual accounts receivable value is unknown

Inventory

-
LIXT annual inventory value is unknown

Liabilities

Total liabilities

$318.30K
LIXT annual total liabilities is $318.30 thousand

Long term liabilities

$0.00
LIXT annual total long term liabilities is $0.00

Current liabilities

$318.30K
LIXT annual total current liabilities is $318.30 thousand

Accounts payable

-
LIXT annual accounts payable value is unknown

Debt

Total debt

$0.00
LIXT annual total debt is $0.00

Total debt 1-year change

0%
LIXT {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
LIXT annual long term debt value is unknown

Short term debt

-
LIXT annual short term debt value is unknown

Equity & Capital

Shareholders equity

$827.20K
LIXT annual stockholders equity is $827.20 thousand

Book value

-$2.67M
LIXT annual book value is -$2.67 million

Retained earnings

-$52.07M
LIXT annual retained earnings is -$52.07 million

Working capital

$827.20K
LIXT annual working capital is $827.20 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$3.16M
LIXT annual cash flow from operations is -$3.16 million

Cash from operations 1-year change

+26.29%
LIXT annual cash flow from operations is up +26.29% year-on-year

Cash from investing

-
LIXT annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
LIXT annual cash flow from investing activities 1-year change is unknown

Cash from financing

$0.00
LIXT annual cash flow from financing activities is $0.00

Cash from financing 1-year change

-100%
LIXT annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

-
LIXT annual capital expenditures value is unknown

CAPEX 1-year change

-
LIXT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$3.16M
LIXT annual free cash flow is -$3.16 million

Free cash flow 1-year change

+26.29%
LIXT annual free cash flow is up +26.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
LIXT annual gross profit margin value is unknown

Operating margin

-
LIXT annual operating profit margin value is unknown

Net margin

-
LIXT annual net profit margin value is unknown

ROA & ROE

ROA

-313.05%
LIXT annual return on assets is -313.05%

ROE

-433.51%
LIXT annual return on equity is -433.51%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LIXT price to earnings ratio value is unknown

PE ratio Sector rank

-
LIXT price to earnings ratio is unknown

PB Ratio

PB ratio

-1.22
LIXT price to book ratio is -1.22

PB ratio Sector rank

7.98%
LIXT price to book ratio is higher than 7.98% of companies in Healthcare sector

PS Ratio

PS ratio

-
LIXT price to sales ratio value is unknown

PS ratio Sector rank

-
LIXT price to sales ratio is unknown

Enterprise value

Enterprise value

$2.21M
LIXT enterprise value is $2.21 million

Enterprise value Sector rank

16.35%
LIXT enterprise value is higher than 16.35% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.62
LIXT EV/EBITDA is -0.62

EV/EBITDA Sector rank

49.09%
LIXT EV/EBITDA is higher than 49.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.60
LIXT annual current ratio is 3.60

Quick ratio

-
LIXT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
LIXT annual debt to equity ratio is 0.00

Interest coverage ratio

-212.45
LIXT annual interest coverage ratio is -212.45

Risk & Stability

Piotroski F-Score

-
LIXT piotroski f-score value is unknown

Altman Z-Score

-
LIXT altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

XRTX logo
XORTX Therapeutics (XRTX)
PALI logo
Palisade Bio (PALI)
EVOK logo
Evoke Pharma (EVOK)
ATNF logo
180 Life Sciences (ATNF)
TLIS logo
Talis Biomedical (TLIS)
INM logo
InMed Pharmaceuticals (INM)
TOVX logo
Theriva Biologics (TOVX)
QNRX logo
Quoin Pharmaceuticals (QNRX)
TTNP logo
Titan Pharmaceuticals (TTNP)
  • What is the ticker symbol for Lixte Biotechnology Holdings?
  • Does Lixte Biotechnology Holdings pay dividends?
  • What sector is Lixte Biotechnology Holdings in?
  • What industry is Lixte Biotechnology Holdings in?
  • What country is Lixte Biotechnology Holdings based in?
  • When did Lixte Biotechnology Holdings go public?
  • Is Lixte Biotechnology Holdings in the S&P 500?
  • Is Lixte Biotechnology Holdings in the NASDAQ 100?
  • Is Lixte Biotechnology Holdings in the Dow Jones?
  • When was Lixte Biotechnology Holdings's last earnings report?
  • When does Lixte Biotechnology Holdings report earnings?

What is the ticker symbol for Lixte Biotechnology Holdings?

The ticker symbol for Lixte Biotechnology Holdings is NASDAQ:LIXT

Does Lixte Biotechnology Holdings pay dividends?

No, Lixte Biotechnology Holdings does not pay dividends

What sector is Lixte Biotechnology Holdings in?

Lixte Biotechnology Holdings is in the Healthcare sector

What industry is Lixte Biotechnology Holdings in?

Lixte Biotechnology Holdings is in the Biotechnology industry

What country is Lixte Biotechnology Holdings based in?

Lixte Biotechnology Holdings is headquartered in United States

When did Lixte Biotechnology Holdings go public?

Lixte Biotechnology Holdings's initial public offering (IPO) was on October 25, 2007

Is Lixte Biotechnology Holdings in the S&P 500?

No, Lixte Biotechnology Holdings is not included in the S&P 500 index

Is Lixte Biotechnology Holdings in the NASDAQ 100?

No, Lixte Biotechnology Holdings is not included in the NASDAQ 100 index

Is Lixte Biotechnology Holdings in the Dow Jones?

No, Lixte Biotechnology Holdings is not included in the Dow Jones index

When was Lixte Biotechnology Holdings's last earnings report?

Lixte Biotechnology Holdings's most recent earnings report was on Nov 12, 2024

When does Lixte Biotechnology Holdings report earnings?

The next expected earnings date for Lixte Biotechnology Holdings is May 9, 2025
On this page